Medeze Group Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Veerapol Khemarangsan

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	14.5yrs
CEO ownership	24.0%
Management average tenure	no data
Board average tenure	5.3yrs

Recent management updates

No updates

Recent updates

CEO

Veerapol Khemarangsan

14.5yrs

Tenure

Dr. Veerapol Khemarangsan is Co-Founder, Chief Executive Officer and Director of Medeze Group Public Company Limited and has been its Director since July 19, 2010. Dr. Khemarangsan has M.D. from Mahidol Un...

Board Members

Name	Position	Tenure	Compensation	Ownership
Veerapol Khemarangsan	Co-Founder	14.5yrs	no data	24.01% THB 2.3b
Supakarn Kijgosol	CFO & Director	6yrs	no data	no data
Phunurai Akkarasacksakun	COO & Director	6yrs	no data	0.56% THB 54.1m
Tanut Kunkanjanawan	Chief Laboratory Officer & Director	6yrs	no data	1.06% THB 101.8m
Rachanee O-charoen	Chief Medical Officer & Director	6yrs	no data	no data
Danita Phithaknetikun	Chief Business Development Officer & Director	6yrs	no data	0.53% THB 51.1m
Wanchai Chantrapitak	Independent Director	4.7yrs	no data	no data
Suphawadee Kongtawee	Independent Director	4.7yrs	no data	no data
Piyawat Ratchapolsitte	Independent Director	2.8yrs	no data	no data
Shivatra Talchai	Independent Director	4.7yrs	no data	no data
Thanabodhi Swasdisri	Independent Director	2.4yrs	no data	no data
Watcharee Tintani	Independent Chairman of the Board	3.8yrs	no data	no data

5.3yrs

Average Tenure

Experienced Board: MEDEZE's board of directors are considered experienced (5.3 years average tenure).

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/02 04:03
End of Day Share Price	2025/01/02 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Medeze Group Public Company Limited is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Wilasinee Boonmasungsong	Globlex Securities Co. Ltd.
Thakol Banjongruck	Yuanta Securities (Thailand) Company Limited